Cancer drugs, though cheaper in the developing world, remain unaffordable in poorer countries

first_img Talia Bronshtein/STAT Source: Global differences in cancer drug prices: A comparative analysis Leave this field empty if you’re human: Many of the countries in the survey have single-payer, government-run health care systems, so those drug costs are coming out of the national treasury, at least in part, as well as from cancer patients who pay some or all of the cost out of pocket.Yet, the sticker prices studied by Goldstein’s team might not perfectly track drug expenditures, because the calculations reflect list prices, not discounted prices. Although drug makers often have discount programs, they are so opaque and difficult to qualify, Goldstein cautioned, that it’s almost impossible to learn what they are.“It’s often a secret,” he said. Cancer patients in the United States may envy the low prices that people in, say, India pay for chemotherapy and other cancer drugs. But in fact, prices are less affordable in low- and middle-income countries, new research shows.And just as poorer countries’ inability to afford HIV/AIDS drugs ignited bitter controversy, the price of cancer drugs “also raises ethical questions,” said Dr. Daniel Goldstein, who presented the findings at the annual meeting of the American Society of Clinical Oncology in Chicago on Monday.“If there are effective cancer therapies available in the West and not in developing countries, it will become a serious issue in coming years,” said Goldstein, an oncologist at Israel’s Rabin Medical Center.advertisement Sharon Begley About the Author Reprints Related: Newsletters Sign up for Daily Recap A roundup of STAT’s top stories of the day. @sxbegle The median price for eight branded cancer drugs such as Avastin and Gleevec ranged from $1,515 in India to $8,694 in the US, the researchers reported. For 15 generics such as docetaxel and paclitaxel, the cost of a month’s supply ranged from $120 in South Africa to $654 in the US.advertisement But US patients were better able to afford the drugs, when “affordability” is calculated as a percentage of per capita gross domestic product required to pay for a month’s supply of the median-priced drug, the study found.Per capita GDP can roughly be thought of as each person’s “share” of a country’s total economic output. By that measure, cancer patients in Australia pay 71 percent of their monthly economic output for a month’s supply of a brand-name cancer drug; it’s 313 percent in India, 286 percent in China, and 192 percent in the US.“The trend we’re seeing is that even though drug prices in India and China are much less than in the US, because their GDP is so much lower, the drugs are significantly less affordable,” Goldstein said.For generics, affordability ranged from 6 percent of monthly per capita GDP in Australia to 8 percent in Israel to 33 percent in India to 48 percent in China. Please enter a valid email address. BusinessCancer drugs, though cheaper in the developing world, remain unaffordable in poorer countries The affordability of cancer drugs remains a problem for many Chinese patients. Eugene Hoshiko/AP Global Differences in Cancer Drug PricesExplore the affordability of brand-name and generic cancer drugs in seven countries with this data visualization. We’ve compared the drug prices to an economics metric known as GDP PPP per capita per month, which stands in for an average individual’s purchasing power. Hover over the data points to see how easy, or hard, it is to afford cancer drugs on a typical monthly income in each country.$0$484$1,091$1,110$2,761$3,319$3,879$4,531GDP PPP ($ per month)IndiaSouth AfricaChinaIsraelUKAustraliaUSPatented drug price as % of GDP PPP100% – monthly GDP PPPGeneric drug price as % of GDP PPP Privacy Policy Sharp rise in cancer drug spending forecast, but access remains a problem Goldstein and his colleagues from four countries calculated the prices of a month’s supply of 23 cancer drugs in Australia, China, India, Israel, South Africa, Great Britain, and the United States. Senior Writer, Science and Discovery (1956-2021) Sharon covered science and discovery. [email protected] By Sharon Begley June 6, 2016 Reprints Tags cancerChinadrug pricesIndialast_img read more

Odds & Ends: Moonlight Scribe Tarell Alvin McCraney to Pen Disney Musical & More

first_imgFrank M. Young Is Dead at 77Frank M. Young has passed away at the age of 77. Young founded both Theatre Under the Stars as well as Seattle’s 5th Avenue Theatre Association, which he ran until 2000. The Seattle theater company, which served as an institution to create new musicals and revive old ones, was where Frank Wildhorn’s Jekyll & Hyde began. The musical went on to bow on the Great White Way in 1997.Andrew Keenan-Bolger & Scott Bixby to Tie the KnotBetween Phillipa Soo and Steven Pasquale and Idina Menzel and Aaron Lohr, love is in the air for stage stars. Former Broadway.com vlogger Andrew Keenan-Bolger and his beau Scott Bixby announced their engagement on September 23. Talk about seizing the day! Take a peek at the adorable engagement pics. The forest setting is giving us major Tuck Everlasting vibes. We said yes! Can’t wait to marry @scottbix! pic.twitter.com/jQ2LLiakTD— Andrew Keenan-Bolger (@KeenanBlogger) September 23, 2017Oscar Nom Andy Garcia Joins Mamma Mia! Sequel in New RoleAnother star has been announced for Mamma Mia! Here We Go Again! Deadline reports that Oscar nominee Andy Jones will join Meryl Streep, Julie Walters, Christine Baranski, Amanda Seyfried, Dominic Cooper and Lily James in the sequel. He will play a new role that has yet to be revealed. The film hits theaters on July 20, 2018.Longtime Drama League Board Members Elected to Executive CommitteeThe Drama League announced that a few of its longtime board members will assume new leadership roles. This new executive committee will include Stan Ponte as President, Bonnie Comley as First Vice President, Broadway.com contributor Kathy Henderson as Second Vice President, Susan Lang as Third Vice President, Anna May Feige as Secretary and Ken Wirth as Treasurer. Congrats to the board members on their new roles!P.S. We love collecting fabulous finds and greeting Broadway favorites at the Broadway Flea Market & Grand Auction, but the annual event is first and foremost for a great cause. This year’s grand total was the first to pass the million dollar mark at $1,023,309 for Broadway Cares/Equity Fights AIDS. Over the course of its 31 years, the event has earned $13.6 million collectively. Hats off to everyone who contributed to the event! Tarell Alvin McCraney(Photo: Getty Images) Tarell Alvin McCraney & David Oyelowo Team Up for New MusicalOscar-winning scribe Tarell Alvin McCraney is writing a Disney musical! Deadline reports that David Oyelowo, last seen on the New York stage in Broadway’s Othello opposite Daniel Craig, will star in the live-action film project, which is currently titled Cyrano the Moor. The musical will combine both Edmond Rostand’s Cyrano de Bergerac and Shakespeare’s Othello. The former follows a Renaissance man with a large nose and little confidence; the latter is a tragedy about a general who murders his own wife. Kristin Chenoweth Celebrates Her 20th Anniversary on Broadway Good news! Besides her high soprano and adorable dog, we have yet another reason to celebrate Kristin Chenoweth. This year, the Tony winner celebrates 20 years since her Broadway debut in a production of Molière’s Scapin. She chatted about it on September 25 on Live with Kelly and Ryan. “It was back when I thought, ‘Oh, I’ll work for free! I’m so happy.’ Now it’s changed a little bit,” she joked. View Commentslast_img read more